ABSTRACT. The renin-angiotensin system is activated by congestive heart failure associated with a ventricular septal defect (VSD). To determine the effect of angiotensinconverting enzyme inhibition on the hemodynamics with VSD, the dose response curve of captopril was measured in lambs. Furthermore, the effect of captopril on the distribution of systemic output was determined by the radionuclide-labeled microsphere technique. A total of 12 lambs (less than 1 month old) with VSD were instrumented and a minimum of five animals was tested for each data point. Captopril(0.05-10 mg/kg) caused dose-dependent vascular changes. At a dose of 2 mg/kg, maximal hemodynamic effects were observed. The systemic resistance fell by 28 f 9% (mean f SD, p < 0.05, n = 9), whereas pulmonary arteriolar resistance rose by 113 f 34% ( p < 0.05). These vascular changes caused a reduction in the ratio of pulmonary to systemic flow from 3. Microsphere-determined organ blood flow to the heart, kidney, liver, duodenum, and skeletal muscle was preserved after a 5 mg/kg dose of captopril and, in fact, tended to increase, but the changes were not significant. The myocardial endocardia1 to epicardial flow ratio increased from 1.17 2 0.27 to 1.49 f 0.14 (+27%, p < 0.05). The data indicate that captopril caused dose-dependent changes in the distribution of left ventricular output in lambs with VSD, reducing total pulmonary flow while preserving organ blood flow. (Pediatr Res 24: 499-503, 1988) Abbreviations VSD, ventricular septal defect ANF, atrial natriuretic factor such, serves an homeostatic role to preserve renal function (5). However, this renal-renin response may further impair cardiac performance by increasing afterload (1). The increased afterload may also aggravate the pathophysiology of structural defects with a left-to-right shunt (6).However, local autoregulation may maintain blood flow to vital organs, offsetting the generalized vasoconstriction due to angiotensin 11. The role of the increased angiotensin I1 production may then be to maintain arterial pressure in the autoregulatory range and to preserve organ blood flow despite a reduction in cardiac output (5). If that were the case, inhibiting the formation of angiotensin I1 with a converting enzyme inhibitor might actually impair renal function and possibly organ blood flow in general if the arterial pressure fell below the autoregulatory range. To test the hypothesis that the stimulation in the renin-angiotensin system with a structural heart defect is pathologic and adversely affects the hemodynamics, we created a VSD in lambs. We then determined the dose reponse characteristics of captopril, an angiotensin-converting enzyme inhibitor. Both the global hemodynamics and the regional organ blood flow effects of captopril were studied in nonanesthetized, chronically instrumented animals with electromagnetic flow probes and radionuclide-labeled microsphere injections.
MATERIALS AND METHODSThe technique used to create the VSD has been previously described (4) and was not significa...